CytomX Therapeutics, Inc. (CTMX) Shareholders’ equity 2016–2025
CytomX Therapeutics, Inc. (CTMX) shareholders’ equity at each fiscal year-end, per SEC filings.
$99.0MFY2025 · since FY2016: $78.5M → $99.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $99.0M | +21812.3% |
| FY2024 | -$456,000 | +99.0% |
| FY2023 | -$47.4M | +44.7% |
| FY2022 | -$85.8M | -18582.1% |
| FY2021 | -$459,000 | +94.1% |
| FY2020 | -$7.8M | -130.5% |
| FY2019 | $25.5M | -81.2% |
| FY2018 | $135.8M | +94.3% |
| FY2017 | $69.9M | -10.9% |
| FY2016 | $78.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice